Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review.

Stojadinovic M, Jankovic S, Zivkovic-Zaric R, Baralic M, Jovicic-Pavlovic S, Bontic A, Petrovic N, Pejcic A

Open source

DOI
10.1007/s00228-025-03913-8
Published
2025 Dec
Container
European journal of clinical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-025-03913-8,
  title = {Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review.},
  author = {Stojadinovic M and Jankovic S and Zivkovic-Zaric R and Baralic M and Jovicic-Pavlovic S and Bontic A and Petrovic N and Pejcic A},
  year = {2025},
  journal = {European journal of clinical pharmacology},
  doi = {10.1007/s00228-025-03913-8},
  url = {https://doi.org/10.1007/s00228-025-03913-8}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review.
AU  - Stojadinovic M
AU  - Jankovic S
AU  - Zivkovic-Zaric R
AU  - Baralic M
AU  - Jovicic-Pavlovic S
AU  - Bontic A
AU  - Petrovic N
AU  - Pejcic A
PY  - 2025
JO  - European journal of clinical pharmacology
DO  - 10.1007/s00228-025-03913-8
UR  - https://doi.org/10.1007/s00228-025-03913-8
ER  - 

APA

M, S., S, J., R, Z., M, B., S, J., A, B., N, P., & A, P. (2025). Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review.. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-025-03913-8

Source records